Idk about all that. There was a reason 4-7 million was the estimate our predecessor Company came up with for the 2b trial. Unless Dr Mennon figured out a way to do the trial with fewer patients I think we are stuck with those costs. I do wonder however how much the P trials will cost though. Perhaps we won't need as many people for that - 50 control and 50 treatment? But you would think they might also want to do some dose optimization so I am defaulting to 8-14 million for the two trials. Maybe a bulk discount if they do everything through the same CRO :)
Market Data 
Markets 
AI
